HLB Therapeutics Co Ltd (115450) Stock Price & News

All values in KRW	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	16,06 mjd	22,78 mjd	13,05 mjd	12,56 mjd
Cost of goods sold	16,93 mjd	15,80 mjd	13,76 mjd	13,93 mjd
Cost of revenue	16,93 mjd	15,80 mjd	13,76 mjd	13,93 mjd
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3,56 mjd	2,86 mjd	2,28 mjd	2,07 mjd
Operating expense	4,56 mjd	2,88 mjd	2,52 mjd	3,36 mjd
Total operating expenses	21,49 mjd	18,68 mjd	16,28 mjd	17,29 mjd
Operating income	-5,43 mjd	4,09 mjd	-3,24 mjd	-4,73 mjd
Other non operating income	98,79 m	-15,45 m	-72,96 k	12,20 m
EBT including unusual items	-5,59 mjd	-1,18 mjd	-4,45 mjd	-8,82 mjd
EBT excluding unusual items	-6,62 mjd	146,67 m	-4,70 mjd	-8,78 mjd
Income tax expense	-	-1,68 mjd	-	223,63 m
Effective tax rate	-	142,88%	-	-2,54%
Other operating expenses	94,74 m	-4,70 m	62,65 m	85,30 m
Net income	-5,48 mjd	642,67 m	-4,32 mjd	-8,87 mjd
Net profit margin	-34,11%	2,82%	-33,11%	-70,59%
Earnings per share	-	-	-	-
Interest and investment income	152,74 m	59,27 m	105,82 m	71,81 m
Interest expense	-327,63 m	-353,28 m	-487,18 m	-514,28 m
Net interest expenses	-174,89 m	-294,02 m	-381,36 m	-442,47 m
Depreciation and amortization charges	222,85 m	235,01 m	262,42 m	262,85 m
EBITDA	-4,97 mjd	4,63 mjd	-2,62 mjd	-4,10 mjd
Gain or loss from assets sale	24,88 m	-	-	40,28 m

Finance